FEIBA-NF factor eight inhibitor bypassing fraction 500U powder for injection vial with diluent vial Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

feiba-nf factor eight inhibitor bypassing fraction 500u powder for injection vial with diluent vial

takeda pharmaceuticals australia pty ltd - factor viii inhibitor bypassing fraction, quantity: 500 u - injection, powder for - excipient ingredients: sodium citrate dihydrate; sodium chloride - feiba-nf is indicated for routine prophylaxis, control of spontaneous bleeding episodes and use in surgery in haemophilia a or b patients with inhibitors.

CSL Brazil Biostate Human Coagulation Factor VIII (Post Clinical Trial Supply), freeze-dried 500 IU, powder for injection vial Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

csl brazil biostate human coagulation factor viii (post clinical trial supply), freeze-dried 500 iu, powder for injection vial

csl behring australia pty ltd - factor viii,von willebrand factor -

CSL Brazil Biostate Human Coagulation Factor VIII (Post Clinical Trial Supply), freeze-dried 250 IU, powder for injection vial Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

csl brazil biostate human coagulation factor viii (post clinical trial supply), freeze-dried 250 iu, powder for injection vial

csl behring australia pty ltd - factor viii,von willebrand factor -

Voncento Европска Унија - Енглески - EMA (European Medicines Agency)

voncento

csl behring gmbh - human coagulation factor viii, human von willebrand factor - hemophilia a; von willebrand diseases - blood coagulation factors, von willebrand factor and coagulation factor viii in combination, antihemorrhagics - von willebrand disease (vwd)prophylaxis and treatment of haemorrhage or surgical bleeding in patients with vwd, when desmopressin (ddavp) treatment alone is ineffective or contraindicated.haemophilia a (congenital factor-viii deficiency)prophylaxis and treatment of bleeding in patients with haemophilia a.

Dried Factor VIII Fraction type 8Y 250unit powder and solvent for solution for injection vials Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

dried factor viii fraction type 8y 250unit powder and solvent for solution for injection vials

bio products laboratory ltd - von willebrand factor; factor viii - powder and solvent for solution for injection - 500unit ; 250unit

Haemate P 600 IU vWF/250 IU FVIII 600 IU - 250 IU inj./inf. sol. (pwdr. + solv.) i.v. vial Белгија - Енглески - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

haemate p 600 iu vwf/250 iu fviii 600 iu - 250 iu inj./inf. sol. (pwdr. + solv.) i.v. vial

csl behring gmbh - human coagulation factor viii 250 iu; human factor von willebrand 600 iu - powder and solvent for solution for injection/infusion - 600 iu - 250 iu - human coagulation factor viii 250 iu; factor von willebrand 600 iu - von willebrand factor and coagulation factor viii in combination

Wilate 1000,1000 IU FVIII/1000 IU VWF inj. sol. (pwdr. + solv.) i.v. vial Белгија - Енглески - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

wilate 1000,1000 iu fviii/1000 iu vwf inj. sol. (pwdr. + solv.) i.v. vial

octapharma benelux sa-nv - human coagulation factor viii 1000 iu; human factor von willebrand 1000 iu - powder and solvent for solution for injection - factor von willebrand 100 iu/ml; human coagulation factor viii 100 iu/ml - von willebrand factor and coagulation factor viii in combination

KOVALTRY 1000 IU Израел - Енглески - Ministry of Health

kovaltry 1000 iu

bayer israel ltd - recombinant human coagulation factor viii - powder and solvent for solution for injection - recombinant human coagulation factor viii 1000 iu - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency). kovaltry can be used for all age groups.

KOVALTRY 2000 IU Израел - Енглески - Ministry of Health

kovaltry 2000 iu

bayer israel ltd - recombinant human coagulation factor viii - powder and solvent for solution for injection - recombinant human coagulation factor viii 2000 iu - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency). kovaltry can be used for all age groups.

KOVALTRY 250 IU Израел - Енглески - Ministry of Health

kovaltry 250 iu

bayer israel ltd - recombinant human coagulation factor viii - powder and solvent for solution for injection - recombinant human coagulation factor viii 250 iu - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency). kovaltry can be used for all age groups.